The DOI matches its Crossref record; 99 of the 104 references it cites were found in a registry or an index.
Epigenetic gene silencing in cancer: the DNA hypermethylome
Open accessAbstract
Epigenetic gene inactivation in transformed cells involves many 'belts of silencing'. One of the best-known lesions of the malignant cell is the transcriptional repression of tumor-suppressor genes by promoter CpG island hypermethylation. We are in the process of completing the molecular dissection of the entire epigenetic machinery involved in methylation-associated silencing, such as DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylases, histone methyltransferases, histone demethylases and Polycomb proteins. The first indications are also starting to emerge about how the combination of cellular selection and targeted pathways leads to abnormal DNA methylation. One thing is certain already, promoter CpG island hypermethylation of tumor-suppressor genes is a common hallmark of all human cancers. It affects all cellular pathways with a tumor-type specific profile, and in addition to classical tumor-suppressor and DNA repair genes, it includes genes involved in premature aging and microRNAs with growth inhibitory functions. The importance of hypermethylation events is already in evidence at the bedside of cancer patients in the form of cancer detection markers and chemotherapy predictors, and in the approval of epigenetic drugs for the treatment of hematological malignancies. In the very near future, the synergy of candidate gene approaches and large-scale epigenomic technologies, such as methyl-DIP, will yield the complete DNA hypermethylome of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the epigenetic landscape of human malignancies exhibits massive reprogramming in their DNA methylation patterns.”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Self-citationmiR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Cited by
Items 601–700 of 725
Epigenetic events in male common urogenital organs cancer
Ahmed, A. A., Musa, H. H., Sifaldin, A. Z., & Musa, T. H. (2016) · Journal of Cancer Research and Practice · doi:10.1016/j.jcrpr.2016.06.004 · Cited by 1
The Future of Discoveries in Breast and Reproductive Cancers: The Genome and Epigenetics
Ropero, S., & Esteller, M. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0477-5_14 · Cited by 1
“[ 19 ]. Table 14.1 shows the most important hypermethylated genes in human cancer reported to date.”
BackgroundInfluentialClinical Epigenetics and Epigenomics
Qiu, C., Yu, F., Deng, H., & Shen, H. (2016) · Translational bioinformatics · doi:10.1007/978-94-017-7543-4_10 · Cited by 1
Breast Cancer Epigenetics: Biomarkers and Therapeutic Potential
Nabilsi, N. H., Pardo, C. E., Zajac‐Kaye, M., & Kladde, M. P. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-634-4_11 · Cited by 1
Anti-Cancer Activity of Herbal Plants
Bharath, A. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-0703-8.ch002 · Cited by 1
Fuso, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-21863-7.00016-0 · Cited by 1
Normalization of qPCR array data: a novel method based on procrustes superimposition
Mohammadian, A., Nourani, M. R., Mowla, S. J., Tavallaei, M., & Liang, Y. (2013) · مجله علوم دانشگاه تهران (منتشر نمی شود) · doi:10.22059/pbs.2013.32090 · Cited by 1
Liu, B., Wang, X. S., Chen, H., Lu, Q., Gershwin, M. E., & Leung, P. S. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800957-4.00004-7 · Cited by 1
Fuso, A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-388415-2.00026-3 · Cited by 1
Fuso, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00031-5 · Cited by 3
Crosstalk between microRNAs and Epigenetics: From the Nutritional Perspective
Liu, Z., Tammen, S. A., Friso, S., & Choi, S. (2013) · Wiley eBooks · doi:10.1002/9781118695999.ch20 · Cited by 1
Wakeman, B. S. (2008) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro) · Cited by 1
Dong, F., Gan, H., Liang Cheng, C., Lee, J., Zhou, H., Sarkaria, J. N., Daniels, D. J., & Zhang, Z. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/114082 · Cited by 1
“It is known for a long time that genomic DNA in most cancer cells is hypomethylated (Eden et al., 2003; Ehrlich, 2009), and yet DNA hypermethylation at TSGs has been frequently reported in many cancer types (Baylin, 2005; Esteller, 2007; Struhl, 2014).”
BackgroundThe Polo-like kinases as recipients and enablers of epigenetic modifications in tumourigenesis
Ward, R. A. (2014) · Scholarship at UWindsor (University of Windsor)
Stone, L. C. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Shigueoka, C. Y. (2013) · Repositório Digital Institucional da UFPR (Universidade Federal do Paraná)
Contribución de la epigenética al manejo personalizado del cáncer
Dávalos, V., & Esteller, M. (2010) · Elsevier eBooks · doi:10.1016/b978-84-458-2025-4.00012-7 · Cited by 1
DNA Methylation Changes in Osteoarthritis
Roach, H. I. (2011) · Springer eBooks · doi:10.1007/978-1-84882-644-1_8 · Cited by 1
Genética del cáncer: un manual básico para cirujanos
Benson, J. R., & Liau, S. (2008) · Clínicas quirúrgicas de Norteamérica
Chen, H., Chedin, F. L., Chang, C., & Leung, P. S. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800957-4.00019-9
Methylation of human papillomavirus DNA : biological significance and clinical utility
Bryant, D. J. (2012) · ORCA Online Research @Cardiff (Cardiff University)
Methylation markers for early breast cancer detection
Suijkerbuijk, K. P. M. (2010) · Utrecht University Repository (Utrecht University)
Epigenetic Determinants of Altered Gene Expression in Schizophrenia: a Dissertation
Huang, H. (2008) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/h312-hs12
“Hypermethylation at the promoters of tumor suppressor genes is also well known to be linked to cancer (Esteller, 2007).”
BackgroundTumor Heterogeneity in Uveal Melanomas
Mensink, H. W. (2010) · EUR Research Repository (Erasmus University Rotterdam)
Modificaciones de la cromatina, regulación génica y cáncer
Villar, M. D. D. (2009) · Dialnet (Universidad de la Rioja) · Cited by 5
Epigenetics and Tumor Suppressor Genes
Guo, M., Liu, X., & Zhang, W. (2012) · InTech eBooks · doi:10.5772/27445
The Molecular Frame of Pancreatic Carcinogenesis
Heßmann, E., Baumgart, S., Chen, N., Singh, S. K., Singh, G., König, A., Neeße, A., & Ellenrieder, V. (2014) · InTech eBooks · doi:10.5772/57422 · Cited by 1
“Most notably, deregulation of epigenetic mechanisms can contribute to cancer development [33-38].”
Saleh, M. (2011) · InTech eBooks · doi:10.5772/22363
“There are currently four known DNMTs; DNMT1, 2, 3A and 3B (Okano et al., 1998).”
BackgroundInfluentialMethylation Detection and Epigenomics in Pancreatic Cancer
Feldmann, G., & Maitra, A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1160-5_10
“lished relatively early on, it is now apparent that such hypomethylation is typically accompanied by hypermethylation at specific gene promoters, particularly of genes involved in tumor suppression (Ting et al. 2006b; Esteller 2007; Iacobuzio-Donahue 2009). Aberrant promoter hypermethylation seems to be an alternative…”
Crosstalk between DNA methylation and histone modifications
Pichler, G. (2012) · doi:10.5282/edoc.14379 · Cited by 2
hMOF and associated proteins in transcription and cancer
Classen, S. (2013) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/16867
Alipour, M. A., Zargar, S. J., Safarian, S., Fouladdel, S., Azizi, E., & Jafargholizadeh, N. (2013) · مجله علوم دانشگاه تهران (منتشر نمی شود) · doi:10.22059/pbs.2013.32091
Genetic and epigenetic characterization of pediatric high hyperdiploid acute lymphoblastic leukemia
Davidsson, J. (2009) · Lund University Publications (Lund University)
Rodrigues-Antunes, S. (2012) · Americanae (AECID Library)
Liu, C., Wang, W., Wang, P., Lin, J., & Liu, F. R. (2014) · Otolaryngology · doi:10.1177/0194599814541629a51
Quantum Chemical Study for Radical-Induced DNA Effects and Damage
Niiya, T., Kimura, M., Tsutsumi, H., Ishizu, T., & Ono, N. (2013) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c13-00541
Sociaux, S. S. (2019)
Andrade, F. D. O. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2011.tde-15072011-103734
Heßmann, E., & Ellenrieder, V. (2013) · Medical Epigenetics · doi:10.1159/000355617
Carlberg, C., Polly, P., Campbell, M. J., & Park, R. (2014)
Efeito da infecção crônica por Toxoplasma gondii durante a sepse polimicrobiana experimental
Souza, M. D. C. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2013.tde-19062013-122137
Epigenetic Epidemiology of Cancer
Risch, A., Sarkisyan, N., Scherf, D., Jacobsson, H., Hagmann, W., & Plass, C. (2011) · Springer eBooks · doi:10.1007/978-94-007-2495-2_13 · Cited by 1
IRS-1 and SOCS2 are key regulators of insulin-like growth factor signaling in intestinal cancer
Ramocki, N. M. (2008) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/3cjy-a678
Development of Bioanalytical Methods for Clinical Applications and Drug Screening
Cai, X. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
Epigenetic Mechanisms Involved in Cancer Stem Cell Profiles
Pavlović, M. D., & Balint, B. (2015) · Springer eBooks · doi:10.1007/978-3-319-25670-2_6
Epigenetische Regulation urologischer Tumoren
Forschung, U. (2015)
Postpartum Breast Cancer in Hispanic Women: Epigenetics and microRNAs
Muñoz-Rodríguez, J. L. (2015) · UA Campus Repository (The University of Arizona)
Events responsible for aberrant genetic and epigenetic codes in cancer
Thiagalingam, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.008
Review Article Epigenetics and Epigenetic Alterations in Pancreatic Cancer
Omura, N., & Goggins, M. (2015)
Regulación epigenética en cáncer de pulmón: implicaciones para el clínico
Rojas, A. P., Bruges, R. E., Cañas, A., & García, L. F. J. (2017) · Universitas Médica · doi:10.11144/javeriana.umed57-3.recp · Cited by 3
“En contraste, el enriquecimiento en los niveles globales de marcas activadoras como la acetilación también está estrechamente relacionado con la hipometilación del ADN y con la activación transcripcional de algunos genes involucrados con la progresión tumoral [18].”
BackgroundMethylation of Wnt Antagonist Genes and Wnt5a as Prognostic Markers in Colorectal Cancer
Rawson, J. B. (2011) · TSpace (University of Toronto)
Watson, M. J. (2016) · OpenCommons at University of Connecticut (University of Connecticut)
Vaitkienė, P. (2013) · Laba (Lietuvos akademinių bibliotekų direktorių asociacija)
Ekram, M. B. (2013) · Louisiana State University · doi:10.31390/gradschool_dissertations.313
Characterizing the prevalence of chromosomal instability in interval colorectal cancer
Cisyk, A. L. (2014) · Mspace (University of Manitoba)
Chiang, T.-C., & Su, L. J. (2015) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6678-8_1
Epigenetic Changes and Epigenetic Targets in Head and Neck Cancer
Peri, S., Andrews, A. J., Bhatia, A. K., & Mehra, R. (2018) · Current cancer research · doi:10.1007/978-3-319-78762-6_12
ASSESSMENT OF A PROGNOSTIC VALUE OF CDKN2A AND TIMP3 GENE METHYLATION IN BLADDER CANCER
Smal, M. P., Nikitchenko, N. V., Rolevich, A. I., Nabebina, T. I., Krasny, S. A., & Гончарова, Р. И. (2018) · Proceedings of the National Academy of Sciences of Belarus Medical series · doi:10.29235/1814-6023-2018-15-3-263-275
Naseer, F. (2019) · Health Care Current Reviews · doi:10.35248/2375-4273.19.07.242
“In PD alpha-synuclein decreased the level of acetylated histone H3 and inhibits histone acetyltransferase enzyme activity by binding to histone proteins [5].”
BackgroundInfluentialMolecular Basis of Laryngeal Carcinogenesis and the Role of Promoter Hypermethylation
Yordanov, S., Tzveova, R., Goranova, T., Pierini, S., Genadieva, M., Konov, D., Popov, T. M., Kaneva, R. P., & Rangachev, Y. (2015) · International Bulletin of Otorhinolaryngology · doi:10.14748/orl.v11i1.6877
Chu, S. (2019) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/79560
Genetic Approaches to Study Transcriptional Activation and Tumor Suppression: A Dissertation
Lin, L. (2012) · eScholarship@UMassChan · doi:10.13028/q44r-af46
Epigenesis in acute myeloid leukemia: an update.
Boles, J., & Tirado, C. A. (2013) · PubMed
Mawlood, K. I., Kadir, D. H., & Al‐Murrani, W. K. (2022) · Research Square · doi:10.21203/rs.3.rs-1280286/v1
Janoueix‐Lerosey, I. (2019) · Springer eBooks · doi:10.1007/978-3-030-18396-7_3
Yao, Y., Liu, K., Wu, Y., Zhou, J., Jin, H., Zhang, Y., & Zhu, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1484394/v1
Martín-Subero, J. I., & Esteller, M. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.009
Wu, H., & Lu, Q. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814307-0.00013-x
Epigenetic Events in Lung Cancer
Romero, O. A., & Sánchez‐Céspedes, M. (2022) · Medical radiology · doi:10.1007/174_2022_299
Current Review on Environmental Factors and Screening of Cancer
Mutte, S. N. V., Sheik, I., Srinivas, G. Y., & Thulluru, A. (2022) · International Journal of Pharmacy and Biomedical Engineering · doi:10.14445/23942576/ijpbe-v9i3p101
Methylation of nonessential genes in cutaneous melanoma – Rule Out hypothesis
Gorlov, I., Conway, K., Edmiston, S. N., Parrish, E., Hao, H., Amos, C. I., Tsavachidis, S., Gorlova, O. Y., Begg, C. B., Hernando, E., et al. (2023) · Melanoma Research · doi:10.1097/cmr.0000000000000881
Data from Pharmacologic Unmasking of Epigenetically Silenced Genes in Breast Cancer
Ostrow, K. L., Park, H. L., Hoque, M. O., Kim, M. S., Liu, J., Argani, P., Westra, W. H., Criekinge, W. V., & Sidransky, D. (2023) · doi:10.1158/1078-0432.c.6517723
Genetics and Epigenetics Conceptual Study in View of Ayurveda
Chandurkar, N. S., Dahat, S., & Gulhane, P. R. (2022) · Asian Pacific Journal of Health Sciences · doi:10.21276/apjhs.2022.9.4.31
Epigenetic Modification of MicroRNAs
Pal, D., Ghatak, S., & Sen, C. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-820719-2.00003-x
Hipermetylacja promotora genu CDH1 w DNA komórek jako biomarker progresji raka jamy ustnej
Rzeszowie, K. C. S.-T. U. S. K. I. F. C. W., & Brodowski, R. (2023) · Wydawnictwo Uniwersytetu Rzeszowskiego eBooks · doi:10.15584/978-83-8277-100-8
An Insight into Mesoporous Silica Nanoparticles: Ray of Hope for Cancer Management
Chauhan, C., Garg, A., & Agrawal, R. (2023) · Current Cancer Therapy Reviews · doi:10.2174/0115733947242447231003035334 · Cited by 2
Epigentic signaling: regulation of cancer stem cells in colorectal cancer
Chhetri, D., Munuswamy‐Ramanujam, G., Kumar, R. C. S., Baskaran, R., Palaniyandi, K., & Gnanasampanthapandian, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-13212-4.00004-0
Tahir, M., Mohamad, D., & Hamid, M. (2023) · Journal of Sulaimani Medical College · doi:10.17656/jsmc.10418
Khurshid, A., Hussain, R., & Farooq, R. (2024) · Current Cancer Therapy Reviews · doi:10.2174/0115733947289705240206074048 · Cited by 1
‘Nomadic’ Hematopoietic Stem Cells Navigate the Embryonic Landscape
Narayan, A. B., Hariom, S. K., Mukherjee, A. P., Das, D., Nair, A., & Nelson, E. J. R. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10843-6
“Unmethylated regions, on the other hand, are associated with open chromatin that corresponds to transcriptional activation, with the balance between these two methylation events modulating gene expression [ 123].”
Medicinal Plants and Phytochemicals Targeting Specific Cancer Pathways and Mechanisms
Ogunlakin, A. D., Akinwumi, I. A., Adebodun, G. O., Adelakun, A. D., Agbara, A. C., Oluwadara, O., Dada, M., Ahuchaogu, A. A., Elbasyouni, A., Adegoke, A. A., et al. (2025) · Springer eBooks · doi:10.1007/978-3-032-01356-9_11
Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment
Tosti, L., Mould, C., Gatehouse, I., Smith, A. C., Ubych, K., Miano, V., Laird, P. W., Kennefick, J., & Neely, R. K. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.101187
Íñiguez-Muñoz, S., Bedoya-López, A. F., Ensenyat-Méndez, M., Llinàs‐Arias, P., Ahn, S., Factor, R. E., Marzese, D. M., & DiNome, M. L. (2025) · Research Square · doi:10.21203/rs.3.rs-7966078/v1
Recent advances in DNA methylation in tumorigenesis and diagnosis
Liu, S., Yao, Y., Li, Z., & Wang, Z. (2025) · MedMat. · doi:10.1097/mm9.0000000000000032 · Cited by 1
Muñiz-Salgado, J. C., Noriega, R. B., Campos-Viguri, G. E., Jiménez‐Wences, H., Martínez-Carrillo, D. N., Alarcón‐Romero, L. D. C., Illades‐Aguiar, B., Fernández‐Tilapa, G., Camacho, J. G. M., López, M. A. J., et al. (2015) · Acta Universitaria · doi:10.15174/au.2014.720
Uzuner, S. Ç. (2013) · The Sydney eScholarship Repository (The University of Sydney)
Epigenetische Regulation urologischer Tumoren
Heinzelmann, J., Stubendorff, B., Jung, V., Baumgart, S., Hölters, S., Unteregger, G., Grimm, J., Linxweiler, J., Janssen, M. W. W., Ohlmann, C., et al. (2015) · Der Urologe · doi:10.1007/s00120-015-3863-7
Assessment of field effect in the cancerous prostate
Haaland, C. M. (2012) · UNM’s Digital Repository (University of New Mexico)
Lodewijk, I., Nunes, S. P., Henrique, R., Jerónimo, C., Dueñas, M., & Paramio, J. M. (2021) · Figshare · doi:10.6084/m9.figshare.14299486
Chaudhry, A., Shah, H., Sheikh, S. E. Z., & Shabbir, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34671-2.00002-5
Metadata
- Authors
- Esteller, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Esteller, Manel
- ORCID
- Esteller, Manel
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-15
- Volume
- 16
- Issue
- R1
- Pages
- R50-R59
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2158207797
- Cited by
- 725
- References
- 104
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 17 · 2023: 34 · 2022: 35 · 2021: 29 · 2020: 17 · 2019: 35 · 2018: 38 · 2017: 44 · 2016: 45 · 2015: 56 · 2014: 36 · 2013: 56 · 2012: 62
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- epigenetic silencing, DNA hypermethylation, methylome, tumor suppressor, DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylase, histone methyltransferase, histone demethylase, Polycomb group proteins, DNA repair genes, microRNA, tumor markers, chemotherapy response prediction, epigenetic drugs, hematologic malignancies
- MeSH terms
- Werner Syndrome Helicase, Aging, Exodeoxyribonucleases, Humans, Neoplasms, RNA, Neoplasm, Werner Syndrome, Genes, Tumor Suppressor, CpG Islands, DNA Methylation, Gene Silencing, MicroRNAs, Epigenesis, Genetic, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.